Changes of serum angiogenic factors concentrations in patients with diabetes and unstable angina pectoris

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Gui, Chun ^a   Li, Shi kang ^a   Nong, Qin ling ^a   Du, Fang ^a   Zhu, Li guang ^a   Zeng, Zhi yu ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenic factors; Collateral vessels; Diabetes; Gensini score; Unstable angina pectoris

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOSTATIN; FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR BB; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VESICULAR TRANSPORT PROTEINS;

EID: 84873953386     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-34     Document Type: Article

References (43)

1. Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, Kirchmair R, Bahlman F, Walter D, Curry C, Hanley A, Isner JM, Losordo DW. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 2005, 111:2073-2085. 10.1161/01.CIR.0000162472.52990.36, 15851615.
2. Han B, Baliqa R, Huang H, Giannone PJ, Bauer JA. Decreased cardiac expression.of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2009, 297:H829-H835. 10.1152/ajpheart.00222.2009, 19561313.
3. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999, 99:2239-2242. 10.1161/01.CIR.99.17.2239, 10226087.
4. Nisanci Y, Sezer M, Umman B, Yilmaz E, Mercanoqlu S, Ozsaruhan O. Relationship between pressure-derived collateral blood flow and diabetes mellitus in patients with stable angina pectoris: a study based on coronary pressure measurement. J Invasive Cardiol 2002, 14:118-122.
5. McDonagh PF, Hokama JY. Microvascular perfusion and transport in the diabetic heart. Microcirculation 2000, 7:163-181.
6. De Boer RA, Pinto YM, Van Veldhuisen DJ. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation 2003, 10:113-126.
7. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 1998, 273:18514-18521. 10.1074/jbc.273.29.18514, 9660821.
8. Peters KG. Vascular endothelial growth factor and the angiopoietins:working together to build a better blood vessel. Circ Res 1998, 83:342-343. 10.1161/01.RES.83.3.342, 9710128.
9. Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY, Kuriyama T, Cheng SH, Gregory RJ, Jiang C. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 2003, 93:664-673. 10.1161/01.RES.0000093984.48643.D7, 12958144.
10. Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 2005, 24:445-456. 10.1038/sj.onc.1208223, 15558023.
11. Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 2001, 152:1247-1254. 10.1083/jcb.152.6.1247, 2199208, 11257124.
12. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389-395. 10.1038/74651, 10742145.
13. Battegay EJ, Rupp J, Iruela-Arispe L, Saqe EH, Pech M. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol 1994, 125:917-928. 10.1083/jcb.125.4.917, 2120083, 7514607.
14. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002, 105:373-379. 10.1161/hc0302.102143, 11804995.
15. Boodhwani M, Sodha NR, Mieno S, Xu SH, Feng J, Ramlawi B, Clements RT, Sellke FW. Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation 2007, 116:I31-I137. 2723770, 17846323.
16. Khazaei M, Fallahzadeh AR, Sharifi MR, Afsharmoqhaddam N, Javanmard SH, Salehi E. Effects of diabetes on myocardial capillary density and serum angiogenesis biomarkers in male rats. Clinics (Sao Paulo) 2011, 66:1419-1424.
17. Blann AD, Belgore FM, McCollum CN, Silverman S, Lip PL, Lip GY. Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes. Clin Sci (Lond) 2002, 102:187-194.
18. Ozturk BT, Bozkurt B, Kerimoglu H, Okka M, Kamis U, Gunduz K. Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. Mol Vis 2009, 15:1906-1914. 2751798, 19784389.
19. Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kira Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 1994, 267:H1948-H1954.
20. Matsunaqa T, Warltier DC, Tessmer J, Weihrauch D, Simons M, Chilian WM. Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. Am J Physiol Heart Circ Physiol 2003, 285:H352-H358.
21. Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004, 110:2355-2360. 10.1161/01.CIR.0000138112.90641.7F, 15302795.
22. Iribarren C, Phelps BH, Darbinian JA, McCluskey ER, Quesenberry CP, Hytopoulos E, Vogelman JH, Orentreich N. Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study. BMC Cardiovasc Disord 2011, 11:31. 10.1186/1471-2261-11-31, 3124417, 21672190.
23. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983, 51:606. 10.1016/S0002-9149(83)80105-2, 6823874.
24. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985, 5:587-592. 10.1016/S0735-1097(85)80380-6, 3156171.
25. Lu J, Yao YY, Dai QM, Ma GS, Zhang SF, Cao L, Ren LQ, Liu NF. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats. Cardiovasc Diabetol 2012, 11:105. 10.1186/1475-2840-11-105, 3527329, 22954171.
26. Huang PH, Chen JW, Lin CP, Chen YH, Wang CH, Leu HB, Lin SJ. Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions. Cardiovasc Diabetol 2012, 11:99. 10.1186/1475-2840-11-99, 3472269, 22894755.
27. Sodha NR, Clements RT, Boodhwani M, Xu SH, Laham RJ, Bianchi C, Sellke FW. Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am J Physiol Heart Circ Physiol 2009, 296:H428-H434. 2643884, 19074676.
28. Lim HS, Lip GY, Blann AD. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 2005, 180:113-118. 10.1016/j.atherosclerosis.2004.11.004, 15823283.
29. Lim HS, Blann AD, Chong AY, Freestone B, Lip GY. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention. Diabetes Care 2004, 27:2918-2924. 10.2337/diacare.27.12.2918, 15562207.
30. Siebert J, Reiwer-Gostomska M, Babinska Z, Mysliwska J, Mysliwski A, Skopinska-Rozewska E, Sommer E, Skopinski P. Low serum angiogenin concentrations in patients with type 2 diabetes. Diabetes Care 2007, 30:3086-3087. 10.2337/dc07-0629, 17878246.
31. Siebert J, Reiwer-Gostomska M, Mysliwska J, Marek N, Raczynska K, Glasner L. Glycemic control influences serum angiogenin concentrations in patients with type 2 diabetes. Diabetes Care 2010, 33:1829-1830. 10.2337/dc10-0130, 2909070, 20484129.
32. Chiarelli F, Pomilio M, Mohn A, Tumini S, Verrotti A, Mezzetti A, Cipollone F, Wasniewska M, Morgese G, Spagnoli A. Serum angiogenin concentrations in young patients with diabetes mellitus. Eur J Clin Invest 2002, 32:110-114. 10.1046/j.0014-2972.2001.00958.x, 11895457.
33. Tello-Montoliu A, Marin F, Patel J, Roldan V, Mainar L, Vicente V, Sogorb F, Lip GY. Plasma angiogenin levels in acute coronary syndromes: implications for prognosis. Eur Heart J 2007, 28:3006-3011. 10.1093/eurheartj/ehm488, 17981827.
34. Marfella R, Esposito K, Nappo F, Siniscalchi M, Sasso FC, Portoghese M, Di Marino MP, Baldi A, Cuzzocrea S, Di Filippo C, Barboso G, Baldi F, Rossi F, D'Amico M, Giugliano D. Expression of Angiogenic Factors During Acute Coronary Syndromes in Human Type 2 Diabetes. Diabetes 2004, 53:2383-2391. 10.2337/diabetes.53.9.2383, 15331549.
35. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998, 83:233-240. 10.1161/01.RES.83.3.233, 9710115.
36. Zhu Y, Lee C, Shen F, Du R, Young WL, Yang GY. Angiopoietin-2 facilitates vascular endothelial growth factor-induced angiogenesis in the mature mouse brain. Stroke 2005, 36:1533-1537. 10.1161/01.STR.0000170712.46106.2e, 15947259.
37. Oshima Y, Oshima S, Nambu H, Kachi S, Takahashi K, Umeda N, Shen J, Dong A, Apte RS, Duh E, Hackett SF, Okoye G, Ishibashi K, Handa J, Melia M, Wiegand S, Yancopoulos G, Zack DJ, Campochiaro PA. Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive. FASEB J 2005, 19:963-965.
38. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60. 10.1126/science.277.5322.55, 9204896.
39. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, Lavie P, Roguin A, Levy AP. Interindividual Heterogeneity in the Hypoxic Regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999, 100:547-552. 10.1161/01.CIR.100.5.547, 10430770.
40. Chong AY, Caine GJ, Freestone B, Blann AD, Lip GYH. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure. J Am Coll Cardiol 2004, 43:423-428. 10.1016/j.jacc.2003.08.042, 15013125.
41. Panchal VR, Rehman J, Nguyen A, Brown JW, Turrentine M, Mahomed Y, March K. Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease. J Am Coll Cardiol 2004, 43:1383-1387. 10.1016/j.jacc.2003.10.063, 15093871.
42. Matsunaga T, Chilian WM, March K. Angiostatin is negatively associated with coronary collateral growth in patients with coronary artery disease. Am J Physiol Heart Circ Physiol 2005, 288(suppl):H2042-H2046.
43. Sherman JA, Hall A, Malenka DJ, De Muinck ED, Simons M. Humoral and cellular factors responsible for coronary collateral formation. Am J Cardiol 2006, 98:1194-1197. 10.1016/j.amjcard.2006.05.046, 17056326.